172 related articles for article (PubMed ID: 31080089)
1. Dual activity of niclosamide to suppress replication of integrated HIV-1 and Mycobacterium tuberculosis (Beijing).
Fan X; Xu J; Files M; Cirillo JD; Endsley JJ; Zhou J; Endsley MA
Tuberculosis (Edinb); 2019 May; 116S():S28-S33. PubMed ID: 31080089
[TBL] [Abstract][Full Text] [Related]
2. In vitro model of mycobacteria and HIV-1 co-infection for drug discovery.
Vijayakumar S; Finney John S; Nusbaum RJ; Ferguson MR; Cirillo JD; Olaleye O; Endsley JJ
Tuberculosis (Edinb); 2013 Dec; 93 Suppl(Suppl):S66-70. PubMed ID: 24388652
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Virulent Mycobacterium tuberculosis and HIV Coinfected Macrophages with Gallium Nanoparticles Inhibits Pathogen Growth and Modulates Macrophage Cytokine Production.
Choi SR; Britigan BE; Narayanasamy P
mSphere; 2019 Jul; 4(4):. PubMed ID: 31341073
[TBL] [Abstract][Full Text] [Related]
4. Characterization of 2-hydroxy-1-naphthaldehyde isonicotinoyl hydrazone as a novel inhibitor of methionine aminopeptidases from Mycobacterium tuberculosis.
John SF; Aniemeke E; Ha NP; Chong CR; Gu P; Zhou J; Zhang Y; Graviss EA; Liu JO; Olaleye OA
Tuberculosis (Edinb); 2016 Dec; 101S():S73-S77. PubMed ID: 27856197
[TBL] [Abstract][Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
6. Replication rates of Mycobacterium tuberculosis in human macrophages do not correlate with mycobacterial antibiotic susceptibility.
Raffetseder J; Pienaar E; Blomgran R; Eklund D; Patcha Brodin V; Andersson H; Welin A; Lerm M
PLoS One; 2014; 9(11):e112426. PubMed ID: 25386849
[TBL] [Abstract][Full Text] [Related]
7. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
8. Non Nucleoside Reverse Transcriptase Inhibitors, Molecular Docking Studies and Antitubercular Activity of Thiazolidin-4-one Derivatives.
Chitre TS; Patil SM; Sujalegaonkar AG; Asgaonkar KD; Khedkar VM; Garud DR; Jha PC; Gaikwad SY; Kulkarni SS; Choudhari A; Sarkar D
Curr Comput Aided Drug Des; 2019; 15(5):433-444. PubMed ID: 30574853
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D inhibits human immunodeficiency virus type 1 and Mycobacterium tuberculosis infection in macrophages through the induction of autophagy.
Campbell GR; Spector SA
PLoS Pathog; 2012; 8(5):e1002689. PubMed ID: 22589721
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Cystatin C in Human Macrophages Improves Anti-Mycobacterial Immune Responses to
Pires D; Calado M; Velez T; Mandal M; Catalão MJ; Neyrolles O; Lugo-Villarino G; Vérollet C; Azevedo-Pereira JM; Anes E
Front Immunol; 2021; 12():742822. PubMed ID: 34867965
[TBL] [Abstract][Full Text] [Related]
11. Autophagy induction targeting mTORC1 enhances Mycobacterium tuberculosis replication in HIV co-infected human macrophages.
Andersson AM; Andersson B; Lorell C; Raffetseder J; Larsson M; Blomgran R
Sci Rep; 2016 Jun; 6():28171. PubMed ID: 27302320
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous Control of SIV Replication Does Not Prevent T Cell Dysregulation and Bacterial Dissemination in Animals Co-Infected with M. tuberculosis.
Moriarty RV; Rodgers MA; Ellis AL; Balgeman AJ; Larson EC; Hopkins F; Chase MR; Maiello P; Fortune SM; Scanga CA; O'Connor SL
Microbiol Spectr; 2022 Jun; 10(3):e0172421. PubMed ID: 35467372
[TBL] [Abstract][Full Text] [Related]
13. Dual-targeted anti-TB/anti-HIV heterodimers.
Alexandrova L; Zicari S; Matyugina E; Khandazhinskaya A; Smirnova T; Andreevskaya S; Chernousova L; Vanpouille C; Kochetkov S; Margolis L
Antiviral Res; 2017 Sep; 145():175-183. PubMed ID: 28743447
[TBL] [Abstract][Full Text] [Related]
14. Anti-mycobacterial activity of some medicinal plants used traditionally by tribes from Madhya Pradesh, India for treating tuberculosis related symptoms.
Gupta VK; Kaushik A; Chauhan DS; Ahirwar RK; Sharma S; Bisht D
J Ethnopharmacol; 2018 Dec; 227():113-120. PubMed ID: 30172059
[TBL] [Abstract][Full Text] [Related]
15. Imidazole-Thiosemicarbazide Derivatives as Potent Anti-
Bekier A; Kawka M; Lach J; Dziadek J; Paneth A; Gatkowska J; Dzitko K; Dziadek B
Cells; 2021 Dec; 10(12):. PubMed ID: 34943984
[No Abstract] [Full Text] [Related]
16. New azaaurone derivatives as potential multitarget agents in HIV-TB coinfection.
Leite DI; Campaniço A; Costa PAG; Correa IA; da Costa LJ; Bastos MM; Moreira R; Lopes F; Jordaan A; Warner DF; Boechat N
Arch Pharm (Weinheim); 2024 Feb; 357(2):e2300560. PubMed ID: 38032154
[TBL] [Abstract][Full Text] [Related]
17. Repurposing Saquinavir for Host-Directed Therapy to Control Mycobacterium Tuberculosis Infection.
Pires D; Valente S; Calado M; Mandal M; Azevedo-Pereira JM; Anes E
Front Immunol; 2021; 12():647728. PubMed ID: 33841429
[TBL] [Abstract][Full Text] [Related]
18. Plants in our combating strategies against Mycobacterium tuberculosis: progress made and obstacles met.
Gupta VK; Kumar MM; Bisht D; Kaushik A
Pharm Biol; 2017 Dec; 55(1):1536-1544. PubMed ID: 28385088
[TBL] [Abstract][Full Text] [Related]
19. [Prospects for development of new antituberculous drugs].
Tomioka H
Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
[TBL] [Abstract][Full Text] [Related]
20. Ga(III) Nanoparticles Inhibit Growth of both Mycobacterium tuberculosis and HIV and Release of Interleukin-6 (IL-6) and IL-8 in Coinfected Macrophages.
Choi SR; Britigan BE; Narayanasamy P
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
